M4MM
Research and Markets Report Sets a $28B Target on Cannabis Tech
DUBLIN – The Cannabis industry has transformed from plant cultivation to infrastructure development. Today, institutional-grade technologies reshape the way the global supply chain works, and the numbers behind this evolution are capturing the attention of ...
Europe Medical Cannabis to Reach $13 Billion by 2034, IMARC Group Reports
NEW YORK – A fresh industry report highlights substantial potential in Europe's regulated medical Cannabis market as more countries refine access rules and patient numbers climb. The analysis from IMARC Group points to steady expansion ...
Bioxyne Double-Strikes in LATAM and Europe
SYDNEY – Bioxyne Limited, an international health and life sciences company focused on the manufacturing and distribution of novel medicines, including medical Cannabis, psilocybin, and MDMA, has signed two new commercial agreements – one stretching ...
TerrAscend Reports Q1 2026 Financial Results
TORONTO – TerrAscend Corp. announced financial results for the first quarter ended March 31, 2026, showing modest year-over-year revenue growth from continuing operations and sustained operational performance across its core Northeast markets. The company reported ...
Trulieve Reports Q1 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first quarter that presents two concurrent narratives – a retail operation contending with sustained pricing pressure, and a company whose federal tax obligations are, for the ...
LEEF Brands Reports Q1 2026 Financial Results
VANCOUVER – LEEF Brands Inc. reported its strongest financial quarter since inception, showing marked operational progress and turning what had been a loss position a year ago into meaningful profitability, all without adding a single ...
GTI Reports Q1 2026 Financial Results
CHICAGO – Green Thumb Industries Inc. released its first-quarter 2026 financial results, highlighting steady performance in a market still marked by price competition and variable demand. The multistate Cannabis operator posted steady revenue growth, alongside ...
Research and Markets Report Sets a $28B Target on Cannabis Tech
DUBLIN – The Cannabis industry has transformed from plant cultivation to infrastructure development. Today, institutional-grade technologies reshape the way the global supply chain works, and the numbers behind this evolution are capturing the attention of ...
Europe Medical Cannabis to Reach $13 Billion by 2034, IMARC Group Reports
NEW YORK – A fresh industry report highlights substantial potential in Europe's regulated medical Cannabis market as more countries refine access rules and patient numbers climb. The analysis from IMARC Group points to steady expansion ...
Bioxyne Double-Strikes in LATAM and Europe
SYDNEY – Bioxyne Limited, an international health and life sciences company focused on the manufacturing and distribution of novel medicines, including medical Cannabis, psilocybin, and MDMA, has signed two new commercial agreements – one stretching ...
Massachusetts Cannabis Rollback Gains Legislative Traction
BOSTON – State election officials have validated more than 78,000 signatures for a measure that would dismantle the commercial side of Massachusetts' recreational Cannabis industry, thrusting the issue back into legislative hands just as the ...
U.S. Cannabis Operators Trail Canadian Counterparts in Valuation Metrics, Tied to Tax Constraints
LOS ANGELES – In the ongoing tug-of-war between regulatory challenges and market potential in the Cannabis sector, a fresh analysis underscores how a longstanding IRS provision continues to weigh on American companies. According to Viridian ...
Trump’s Rescheduling Order Ignites State Cannabis Momentum in Pennsylvania, Tennessee, and Wyoming
LOS ANGELES – President Donald Trump's directive last week to fast-track Cannabis's rescheduling has handed lawmakers in several conservative-leaning states a timely political opening to advance Cannabis reforms. The executive order, signed on December 18, ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors wrapped up 2025 on a high note, with federal policy breakthroughs and corporate maneuvers signaling sustained growth potential across Cannabis & Psychedelics. Over the past two weeks, President Trump's ...
Texas Awards $50M Grant to Spearhead Ibogaine Trials
AUSTIN – The Texas Health and Human Services Commission has granted $50 million to a statewide consortium led by UTHealth Houston and the University of Texas Medical Branch at Galveston, marking the formal launch of ...
Vireo Growth Acquires PharmaCann Colorado Assets
DENVER – Vireo Growth Inc. reached an agreement with PharmaCann Inc. to buy its 17 operational dispensaries and related assets in Colorado for roughly $49 million in company shares, a move that bolsters Vireo's retail ...
Michigan Senate Tightens Controls on Intoxicating Hemp Derivatives
LANSING – In a bipartisan push to close regulatory gaps, the Michigan Senate approved a package of bills that would classify most high-potency hemp-derived THC items as Cannabis, folding them into the state's established Cannabis ...
Trulieve Secures $140M in Senior Notes
TALLAHASSEE – Trulieve Cannabis Corp. wrapped up a $140 million private placement of 10.5% senior secured notes, tapping into robust investor appetite to fuel its operational push. The deal, upsized from initial plans, comes just ...
🚨🚨 BREAKING: TRUMP RESCHEDULES CANNABIS 🚨🚨
WASHINGTON, D.C. –After months of speculation, President Trump Issues Executive Order Directing Federal Rescheduling of Cannabis to Schedule III President Donald Trump has signed an executive order directing federal agencies to complete the rescheduling of ...
Czech Republic Approves Psilocybin Therapy Guidelines for 2026
PRAGUE – The Czech Republic has taken a measured step toward integrating psychedelic-assisted therapy into its healthcare system, approving detailed rules that will permit the controlled use of psilocybin for select patients beginning in January ...
MSOS ETF Rally Hints at Bigger Gains Ahead, Zuanic Report Finds
LOS ANGELES – A recent report from equity research firm Zuanic & Associates outlines substantial financial gains for U.S. MSOs if federal regulators shift Cannabis to Schedule III status, with savings potentially exceeding hundreds of ...
Organigram Reports Q4 2025 Financial and Full Fiscal Year Results
TORONTO – Organigram Global Inc. released its record Q4 and fiscal 2025 results, showing substantial gains in revenue and profitability metrics despite a quarterly net loss tied to one-time charges. For the fourth quarter, gross ...
The Supreme Court Declines to Resolve Federal Cannabis Prohibition—And the Silence Speaks Volumes
WASHINGTON, D.C. – In its December Orders List, the U.S. Supreme Court declined to hear a case that many hoped would finally force a reckoning between federal Cannabis prohibition and state-legal markets. By declining review, ...
Canopy Growth Acquires MTL Cannabis in Bid to Ramp Up Medical Sales
SMITHS FALLS – Canopy Growth Corp., a major player in the Canadian Cannabis sector, has signed a definitive agreement to purchase MTL Cannabis Corp. in a cash-and-stock transaction worth about $125 million on a fully ...
Trump Sets Plans for Cannabis Reclassification Executive Order
WASHINGTON – President Donald Trump is set to direct federal agencies to reclassify Cannabis from its current Schedule I status to Schedule III under the Controlled Substances Act, a step that would align federal oversight ...
